Interventional Glaucoma

Michael R. Robinson, MD, shares the highlights of the study "Single administration of intracameral bimatoprost implant 10 µg: IOP lowering and safety," presented during the virtual AAO 2020 meeting.

Davinder Grover, MD, MPH, speaks on the highlights of his presentation regarding outcomes of a 12-year study comparing ab externo vs ab interno xen gel stents in tertiary glaucoma practice.

In this roundtable, members of the Ophthalmology Times Europe® Editorial Advisory Board consider the top challenges and opportunities that they anticipate will affect ophthalmology in Europe in 2021.

Goniotomy-viscodilation cataract surgery controls IOP without medications.

Innovation, change has dominated the glaucoma specialty over the years.

Programs use detection and treatment to ease burden of eye disease.

Sustained release helps mitigate disease progression without impacting quality of life.

Pharmaceutical representatives share what keeps them up at night within the ophthalmic space.

In this fourth installment on "2020 vision," pharmaceutical representatives share their outlook on what lies ahead for glaucoma innovations within the ophthalmic space.

Glaucoma Research Foundation (GRF) Ambassadors webinar provides platform for idea-sharing by ophthalmologists

Evidence-based medicine can lead to personalized care, better results for patients

One ophthalmic practice's staff has found that, despite the challenges faced healthcare professionals are facing amid the coronavirus pandemic, a few proverbial “silver lining” practice adaptations will endure long after the crisis is over.

Gonioscopy may offer a reasonable and cost-effective method to evaluate the function of the trabecular micro-bypass device post-implantation and it could help in adjusting the therapy after the surgery.

Options can reduce the treatment burden for patients, leading to improved outcomes

Investigators note the need for less medication over 12-month period

How gonioscopy can offer ophthalmologists an option in treating patients with glaucoma

Researchers must weigh emotional, financial, and reputational considerations

Trabeculectomy may offer better results with more severe glaucoma

Technology is off to a good start, but improvements still needed

New research is looking past just regulating the IOP, using a single-cell RNA to identify 12 distinct cell types in trabecular meshwork.

Diagnostic and monitoring advances in glaucoma need fine-tuning

With an eye on innovation, money is driving research of new therapies and devices.

Canadian ophthalmologists receive updates on best practices amid coronavirus outbreak

Industry develops creative approaches to help increase patient medication adherence